The purpose of this study is to determine whether methamphetamine-dependent individuals will
use less methamphetamine when treated with naltrexone. The study will also investigate
whether individuals with the mu opioid receptor gene variant A118G will use less
methamphetamine than individuals without A118G.
Phase:
Phase 2
Details
Lead Sponsor:
California Pacific Medical Center Research Institute